Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
KCNIP1 antisense RNA 2 (KCNIP1-AS2)
- Target
- KCNIP1-AS2
- Molecular classification
- Long non-coding RNA (lncRNA), Other (not a protein, enzyme, channel, transporter, or receptor)
01
Overview
KCNIP1 antisense RNA 2 (KCNIP1-AS2) is a long non-coding RNA gene annotated in the human genome[5]. Unlike the closely related KCNIP1 gene, which encodes a protein involved in regulation of potassium channel function, KCNIP1-AS2 does not code for a protein and is not a known receptor, channel, enzyme, or other classical molecular target. There is currently no published literature describing its biological function, disease association, or potential as a therapeutic target. Its designation as an "antisense" RNA suggests it may act in regulating expression of the KCNIP1 gene, but this function has not been experimentally verified in public references.
- Other names
- KCNIP1-AS2
02
Biological functions
No experimentally validated function for KCNIP1-AS2 is reported in current public sources. Its role, if any, is likely regulatory, as with many antisense RNAs, but this remains speculative.
03
Disease associations
No known disease associations are established for KCNIP1-AS2. While its sense gene KCNIP1 has links to epilepsy, atrial fibrillation, and related disorders[3][6], no such data are available for KCNIP1-AS2[5].
Beyond the preview
Go deeper on KCNIP1 antisense RNA 2 (KCNIP1-AS2).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on KCNIP1 antisense RNA 2 (KCNIP1-AS2).